Skip to main content
Erschienen in: European Surgery 5/2015

01.10.2015 | Short Communication

Selected commentary to “Treatment of Barrett’s esophagus with a novel focal cryoablation device: a safety and feasibility study”

verfasst von: I. Kristo, MD, F. M. Riegler, MD, R. Asari, MD, E. Cosentini, MD, Univ.-Prof. Dr. S. F. Schoppmann, MD

Erschienen in: European Surgery | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Excerpt

Barrett’s esophagus (BE) is caused by gastroesophageal reflux disease (GERD) and harbors an increased risk for esophageal cancer [13]. Via a sequence involving low- (LGD) and high-grade dysplasia (HGD), esophageal adenocarcinoma may develop (annual cancer risk: 0.1–0.7 %) [4, 5]. Indefinite for dysplasia (ID) defines a condition where the presence or absence of dysplasia cannot be accurately assessed, due to inflammatory changes in the mucosa. Re-endoscopy and biopsy sampling is recommended after a 3–4 weeks course of double dose proton pump inhibitor (PPI) therapy p.o. (i.e. 2 × 40 mg PPI). Diagnosis of BE is established if biopsies obtained from endoscopically visible segments, tongues or islands of columnar lined esophagus (CLE) contain goblet cells ± LGD, HGD or cancer [6]. …
Literatur
1.
Zurück zum Zitat Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Review on the annual cancer risk of Barrett’s esophagus in persons with symptoms of gastroesophageal reflux disease. Anticancer Res. 2012;32(12):5465–73.PubMed Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Review on the annual cancer risk of Barrett’s esophagus in persons with symptoms of gastroesophageal reflux disease. Anticancer Res. 2012;32(12):5465–73.PubMed
2.
Zurück zum Zitat Kristo I, Schoppmann SF. Diagnosis and treatment of benign esophageal diseases. Eur Surg. 2015. (Epub ahead of print) Kristo I, Schoppmann SF. Diagnosis and treatment of benign esophageal diseases. Eur Surg. 2015. (Epub ahead of print)
3.
Zurück zum Zitat Chandrasoma PT. Columnar lined esophagus: what it is and what it tells us. Eur Surg. 2006;38(3):197–209.CrossRef Chandrasoma PT. Columnar lined esophagus: what it is and what it tells us. Eur Surg. 2006;38(3):197–209.CrossRef
4.
Zurück zum Zitat Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center. Anticancer Res. 2013;33(5):2085–91.PubMed Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center. Anticancer Res. 2013;33(5):2085–91.PubMed
5.
Zurück zum Zitat Riegler FM. Barrett’s esophagus: filling the gap. Eur Surg. 2010;42(1):1–3.CrossRef Riegler FM. Barrett’s esophagus: filling the gap. Eur Surg. 2010;42(1):1–3.CrossRef
6.
Zurück zum Zitat Lenglinger J, See SF, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr. 2013;125(19–20):577–90.CrossRefPubMed Lenglinger J, See SF, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr. 2013;125(19–20):577–90.CrossRefPubMed
7.
Zurück zum Zitat Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett’s esophagus and confirmed low-grade dysplasia. Gastroenterology. 2015. (Epub ahead of print) Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett’s esophagus and confirmed low-grade dysplasia. Gastroenterology. 2015. (Epub ahead of print)
8.
Zurück zum Zitat Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Pietro M D, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB, Registry UR. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut. 2015;64(8):1192–9.PubMedCentralCrossRefPubMed Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Pietro M D, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB, Registry UR. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut. 2015;64(8):1192–9.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BL, Schumacher B, Rembacken B, Meining A, Messmann H, Schoon EJ, Gossner L, Mannath J, Seldenrijk CA, Visser M, Lerut T, Seewald S, Ten Kate FJ, Ell C, Neuhaus H, Bergman JJ. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut. 2015. (Epub ahead of print) Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BL, Schumacher B, Rembacken B, Meining A, Messmann H, Schoon EJ, Gossner L, Mannath J, Seldenrijk CA, Visser M, Lerut T, Seewald S, Ten Kate FJ, Ell C, Neuhaus H, Bergman JJ. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut. 2015. (Epub ahead of print)
10.
Zurück zum Zitat Mestari I, Beller L, Fischer-See S, Schoppmann S, Lenglinger J, Wrba F, Riegler M, Zacherl J. Radiofrequency ablation of Barrett’s esophagus and early cancer within the background of the pathophysiology of the disease. Eur Surg. 2012;44(6):366–82.CrossRef Mestari I, Beller L, Fischer-See S, Schoppmann S, Lenglinger J, Wrba F, Riegler M, Zacherl J. Radiofrequency ablation of Barrett’s esophagus and early cancer within the background of the pathophysiology of the disease. Eur Surg. 2012;44(6):366–82.CrossRef
11.
Zurück zum Zitat Arora G, Basra S, Roorda AK, Triadafilopoulos G. Radiofrequency ablation of Barrett’s esophagus. Eur Surg. 2009;41(1):19–25.CrossRef Arora G, Basra S, Roorda AK, Triadafilopoulos G. Radiofrequency ablation of Barrett’s esophagus. Eur Surg. 2009;41(1):19–25.CrossRef
12.
Zurück zum Zitat Subramanian CR, Triadafilopoulos G. Radiofrequency-based treatments for esophageal disease. Eur Surg. 2014;46(1):12–20.CrossRef Subramanian CR, Triadafilopoulos G. Radiofrequency-based treatments for esophageal disease. Eur Surg. 2014;46(1):12–20.CrossRef
13.
Zurück zum Zitat Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D, Dunn JM, Gupta A, Sweis R, Miah H, Morris D, Smart HL, Bhandari P, Willert R, Fullarton G, Morris J, Pietro M D, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O’Toole D, Cheong E, Direkze NC, Ang Y, Veitch A, Dhar A, Nyalender D, Ragunath K, Leahy A, Fullard M, Rodriguez-Justo M, Novelli M, Lovat LB. Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Endoscopy. 2015. (Epub ahead of print) Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D, Dunn JM, Gupta A, Sweis R, Miah H, Morris D, Smart HL, Bhandari P, Willert R, Fullarton G, Morris J, Pietro M D, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O’Toole D, Cheong E, Direkze NC, Ang Y, Veitch A, Dhar A, Nyalender D, Ragunath K, Leahy A, Fullard M, Rodriguez-Justo M, Novelli M, Lovat LB. Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Endoscopy. 2015. (Epub ahead of print)
14.
Zurück zum Zitat Kristo I, Asari R, Rieder E, Riegler V, Schoppmann SF. Treatment of Barrett’s esophagus: update on new endoscopic surgical modalities. Minerva Chir. 2015;70(2):107–18.PubMed Kristo I, Asari R, Rieder E, Riegler V, Schoppmann SF. Treatment of Barrett’s esophagus: update on new endoscopic surgical modalities. Minerva Chir. 2015;70(2):107–18.PubMed
15.
Zurück zum Zitat Scholvinck DW, Kunzli HT, Kestens C, Siersema PD, Vleggaar FP, Canto MI, Cosby H, Abrams JA, Lightdale CJ, Tejeda-Ramirez E, DeMeester SR, Greene CL, Jobe BA, Peters J, Bergman JJ, Weusten BL. Treatment of Barrett’s esophagus with a novel focal cryoablation device: a safety and feasibility study. Endoscopy. 2015. (Epub ahead of print) Scholvinck DW, Kunzli HT, Kestens C, Siersema PD, Vleggaar FP, Canto MI, Cosby H, Abrams JA, Lightdale CJ, Tejeda-Ramirez E, DeMeester SR, Greene CL, Jobe BA, Peters J, Bergman JJ, Weusten BL. Treatment of Barrett’s esophagus with a novel focal cryoablation device: a safety and feasibility study. Endoscopy. 2015. (Epub ahead of print)
16.
Zurück zum Zitat Verbeek RE, Vleggaar FP, Ten Kate FJ, van Baal JW, Siersema PD. Cryospray ablation using pressurized CO2 for ablation of Barrett’s esophagus with early neoplasia: early termination of a prospective series. Endosc Int open. 2015;3(2):E107–E12.PubMedCentralCrossRefPubMed Verbeek RE, Vleggaar FP, Ten Kate FJ, van Baal JW, Siersema PD. Cryospray ablation using pressurized CO2 for ablation of Barrett’s esophagus with early neoplasia: early termination of a prospective series. Endosc Int open. 2015;3(2):E107–E12.PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Gosain S, Mercer K, Twaddell WS, Uradomo L, Greenwald BD. Liquid nitrogen spray cryotherapy in Barrett’s esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc. 2013;78(2):260–5.CrossRefPubMed Gosain S, Mercer K, Twaddell WS, Uradomo L, Greenwald BD. Liquid nitrogen spray cryotherapy in Barrett’s esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc. 2013;78(2):260–5.CrossRefPubMed
18.
Zurück zum Zitat Shaheen NJ, Greenwald BD, Peery AF, Dumot JA, Nishioka NS, Wolfsen HC, Burdick JS, Abrams JA, Wang KK, Mallat D, Johnston MH, Zfass AM, Smith JO, Barthel JS, Lightdale CJ. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc. 2010;71(4):680–5.PubMedCentralCrossRefPubMed Shaheen NJ, Greenwald BD, Peery AF, Dumot JA, Nishioka NS, Wolfsen HC, Burdick JS, Abrams JA, Wang KK, Mallat D, Johnston MH, Zfass AM, Smith JO, Barthel JS, Lightdale CJ. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc. 2010;71(4):680–5.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Greenwald BD, Dumot JA. Cryotherapy for Barrett’s esophagus and esophageal cancer. Curr Opin Gastroenterol. 2011;27(4):363–7.CrossRefPubMed Greenwald BD, Dumot JA. Cryotherapy for Barrett’s esophagus and esophageal cancer. Curr Opin Gastroenterol. 2011;27(4):363–7.CrossRefPubMed
20.
Zurück zum Zitat Friedland S, Triadafilopoulos G. A novel device for ablation of abnormal esophageal mucosa (with video). Gastrointest Endosc. 2011;74(1):182–8.CrossRefPubMed Friedland S, Triadafilopoulos G. A novel device for ablation of abnormal esophageal mucosa (with video). Gastrointest Endosc. 2011;74(1):182–8.CrossRefPubMed
21.
Zurück zum Zitat Lenglinger J, See SF, Beller L, Cosentini E, Asari R, Wrba F, Riegler M, Schoppmann SF. The cardia: esophageal or gastric? Critical reviewing the anatomy and histopathology of the esophagogastric junction. Acta Chir Iugosl. 2012;59(3):15–26.CrossRefPubMed Lenglinger J, See SF, Beller L, Cosentini E, Asari R, Wrba F, Riegler M, Schoppmann SF. The cardia: esophageal or gastric? Critical reviewing the anatomy and histopathology of the esophagogastric junction. Acta Chir Iugosl. 2012;59(3):15–26.CrossRefPubMed
Metadaten
Titel
Selected commentary to “Treatment of Barrett’s esophagus with a novel focal cryoablation device: a safety and feasibility study”
verfasst von
I. Kristo, MD
F. M. Riegler, MD
R. Asari, MD
E. Cosentini, MD
Univ.-Prof. Dr. S. F. Schoppmann, MD
Publikationsdatum
01.10.2015
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 5/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0340-x

Weitere Artikel der Ausgabe 5/2015

European Surgery 5/2015 Zur Ausgabe